Kevin Church

Insider Reports History

Entity
Individual
Location
4000 Mason Road, Suite 300, Box 352141, Seattle, Washington
Signature
/s/ Mark Worthington, Attorney-in-Fact on behalf of Kevin Church
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Church:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Athira Pharma, Inc. CHIEF SCIENTIFIC OFFICER Common Stock 92.7K $52.5K $0.57 Sep 5, 2024 Direct
Athira Pharma, Inc. CHIEF SCIENTIFIC OFFICER Stock Option (Right to Buy) 220K Feb 14, 2024 Direct

Insider Reports Filed by Kevin Church

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATHA Athira Pharma, Inc. Sep 3, 2024 3 $5.21K 4 Sep 5, 2024 CHIEF SCIENTIFIC OFFICER
ATHA Athira Pharma, Inc. Feb 14, 2024 1 $0 4 Feb 16, 2024 CHIEF SCIENTIFIC OFFICER
ATHA Athira Pharma, Inc. Jan 4, 2024 4 -$517 4/A Feb 16, 2024 CHIEF SCIENTIFIC OFFICER
ATHA Athira Pharma, Inc. Jan 4, 2024 4 -$517 4 Jan 8, 2024 Chief Scientific Officer
ATHA Athira Pharma, Inc. Mar 24, 2023 2 $8.65K 4 Mar 27, 2023 Chief Scientific Officer
ATHA Athira Pharma, Inc. Jan 19, 2023 2 $1.8K 4 Jan 23, 2023 Executive VP, Research
ATHA Athira Pharma, Inc. Oct 28, 2022 2 $5K 4 Oct 31, 2022 Executive VP, Research
ATHA Athira Pharma, Inc. Jun 22, 2022 2 -$7.03K 4 Jun 24, 2022 Executive VP, Research
ATHA Athira Pharma, Inc. Jun 8, 2022 3 $5.09K 4 Jun 10, 2022 Executive VP, Research
ATHA Athira Pharma, Inc. Feb 18, 2022 2 $3.75K 4 Feb 18, 2022 Executive VP, Research
ATHA Athira Pharma, Inc. Jan 18, 2022 2 $1.2K 4 Jan 20, 2022 Executive VP, Research
ATHA Athira Pharma, Inc. Jun 8, 2021 2 $3.28K 4 Jun 9, 2021 Vice President of Discovery
ATHA Athira Pharma, Inc. May 18, 2021 3 $5.95K 4/A Jun 10, 2021 Vice President of Discovery